Glycoprotein 88 (GP-88) serum levels as a marker of response to therapy in patients with metastatic breast cancer

被引：0
|
作者：
Tkaczuk, Katherine H. R.
Rosenbatt, Paula
Sulkowski, Sarah
Tait, Nancy
Yue, Binbin
Serrero, Ginette
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
PROGRANULIN; SURVIVAL;
D O I：
10.1158/1538-7445.SABCS21-OT1-05-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-05-01
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Serum hepatocyte growth factor (HGF) levels in patients with progressive metastatic breast cancer
    Maemura, M
    Iino, Y
    Yokoe, T
    Horiguchi, J
    Takei, H
    Nagaoka, H
    Matsumoto, H
    Morishita, Y
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S14 - S14
  • [42] Effect of trastuzumab-based therapy on serum activin A levels in metastatic breast cancer.
    Zubritsky, L. M.
    Ali, S. M.
    Leitzel, K.
    Koestler, W.
    Fuchs, E-M
    Costa, L.
    Knight, R.
    Laadem, A.
    Sherman, M. L.
    Lipton, A.
    CANCER RESEARCH, 2012, 72
  • [43] CD4 levels as a prognostic marker for metastatic breast cancer
    Boyle, H. J.
    Tredan, O.
    Chabaud, S.
    Bajard, A.
    Perol, D.
    Bachelot, T. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Elevation of serum tumor marker CA 15.3 levels as the first manifestation of metastatic breast cancer to the cavernous sinus
    Chandran, R
    Lee, AG
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1998, 18 (03) : 176 - 177
  • [45] PET assessment of response to tamoxifen therapy in patients with metastatic breast cancer.
    Flanagan, FL
    Dehdashti, F
    Mortimer, JE
    Siegel, BA
    Jonson, S
    Welch, MJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 387 - 387
  • [46] Neutralization of the autocrine growth factor PCDGF/GP88 by treatment with anti-PCDGF/GP88 monoclonal antibody restores tamoxifen responsiveness in tamoxifen resistant human breast cancer cells
    Serrero, G
    Dai, H
    Yue, B
    Tian, C
    Tangkeangsirisin, W
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S33 - S33
  • [47] Changes in chromogranin A serum levels during endocrine therapy in metastatic prostate cancer patients
    Sasaki, T
    Komiya, A
    Suzuki, H
    Shimbo, M
    Ueda, T
    Akakura, K
    Ichikawa, T
    EUROPEAN UROLOGY, 2005, 48 (02) : 224 - 230
  • [48] THE EFFECT OF ANTIESTROGEN THERAPY ON SERUM IMMUNOGLOBULIN LEVELS IN BREAST-CANCER PATIENTS
    PAAVONEN, T
    ARONEN, H
    PYRHONEN, S
    ANDERSSON, LC
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (03) : 324 - 324
  • [49] INCREASED SERUM LEVELS OF HGF IN RESPONSE TO SURGICAL MANAGEMENT OF BREAST CANCER PATIENTS
    Georgiou, G. P.
    Provatopoulou, X.
    Kalogera, E.
    Matiatou, M. A.
    Kalles, V.
    Papapanagiotou, I. K.
    Zografos, G.
    Gounaris, A.
    BREAST, 2013, 22 : S23 - S24
  • [50] TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
    Wu, Kunlin
    Zhang, Huihao
    Fu, Yajuan
    Zhu, Youzhi
    Kong, Lingjun
    Chen, Ling
    Zhao, Feng
    Yu, Liangfei
    Chen, Xiangjin
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 3411 - 3420
12345